Clinical Trial Update: A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis [NA]

View source ↗

Summary

A clinical trial investigating minimal residual disease in patients with systemic light-chain (AL) amyloidosis, sponsored by Peking University First Hospital, c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Light-chain Amyloidosis

Snippet

Sponsor: Peking University First Hospital | Conditions: Light Chain (AL) Amyloidosis, MRD | NA | Status: NOT_YET_RECRUITING